Detalhe da pesquisa
1.
Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention.
Cardiovasc Diabetol
; 23(1): 114, 2024 Mar 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38555431
2.
Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study.
Cardiovasc Drugs Ther
; 2023 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37097381
3.
Favorable Prognosis in Patients with Recovered Pulmonary Hypertension after TAVI: An Analysis of the LAPLACE-TAVI Registry.
J Clin Med
; 12(2)2023 Jan 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36675658
4.
Long-term impact of ß-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention.
ESC Heart Fail
; 9(1): 545-554, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34811932
5.
Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axis.
Sci Rep
; 12(1): 5129, 2022 03 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35332212
6.
Capture of Part of a Vessel Wall by a Coronary Orbital Atherectomy System.
CJC Open
; 4(11): 994-995, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-36444367